The retina as a window to the brain—from eye research to CNS disorders

A London, I Benhar, M Schwartz - Nature Reviews Neurology, 2013 - nature.com
Philosophers defined the eye as a window to the soul long before scientists addressed this
cliché to determine its scientific basis and clinical relevance. Anatomically and …

At the interface of sensory and motor dysfunctions and Alzheimer's disease

MW Albers, GC Gilmore, J Kaye, C Murphy… - Alzheimer's & …, 2015 - Elsevier
Recent evidence indicates that sensory and motor changes may precede the cognitive
symptoms of Alzheimer's disease (AD) by several years and may signify increased risk of …

[HTML][HTML] Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging

CB Rickman, S Farsiu, CA Toth… - … ophthalmology & visual …, 2013 - jov.arvojournals.org
Age-related macular degeneration is the leading cause of irreversible visual dysfunction in
individuals over 65 in Western Society. Patients with AMD are classified as having early …

Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma

K Zhang, L Zhang, RN Weinreb - Nature reviews Drug discovery, 2012 - nature.com
Blindness affects 60 million people worldwide. The leading causes of irreversible blindness
include age-related macular degeneration, retinal vascular diseases and glaucoma. The …

Parallel findings in age-related macular degeneration and Alzheimer's disease

K Ohno-Matsui - Progress in retinal and eye research, 2011 - Elsevier
Age is a common risk factor for Alzheimer's disease (AD) and age-related macular
degeneration (AMD). Because of the increasing age of the population, these two age-related …

Age-related macular degeneration (AMD): Alzheimer's disease in the eye?

K Kaarniranta, A Salminen… - Journal of …, 2011 - content.iospress.com
Age-related macular degeneration (AMD) is a late-onset, neurodegenerative retinal disease
that shares several clinical and pathological features with Alzheimer's disease (AD) …

Visual and ocular manifestations of Alzheimer's disease and their use as biomarkers for diagnosis and progression

FZ Javaid, J Brenton, L Guo, MF Cordeiro - Frontiers in neurology, 2016 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia affecting the growing aging
population today, with prevalence expected to rise over the next 35 years. Clinically, patients …

[HTML][HTML] Amyloid-β deposits lead to retinal degeneration in a mouse model of Alzheimer disease

A Ning, J Cui, E To, KH Ashe… - … ophthalmology & visual …, 2008 - tvst.arvojournals.org
purpose. To compare the temporal and spatial expression patterns of amyloid precursor
protein (APP), amyloid-β deposits, inflammatory chemokines, and apoptosis in the retina of a …

SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease

K Murakami, N Murata, Y Noda, S Tahara… - Journal of Biological …, 2011 - ASBMB
Oxidative stress is closely linked to the pathogenesis of neurodegeneration. Soluble amyloid
β (Aβ) oligomers cause cognitive impairment and synaptic dysfunction in Alzheimer disease …

Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration

A Swaroop, EY Chew, C Bowes Rickman… - Annual review of …, 2009 - annualreviews.org
Aging-associated neurodegenerative diseases significantly influence the quality of life of
affected individuals. Genetic approaches, combined with genomic technology, have …